CCND1 and lung carcinoma: This is consistent with previous literature which implicates cyclin D1 downregulation in S phase arrest, including in resveratrol-treated CRC cells (Wolter et al., 2001) and PM2.5-exposed lung carcinoma cells (Zhang et al., 2019).